Mitoquinone pills to prevent COVID-19 after risky exposure
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether an oral medication (mitoquinone/mitoquinol) taken after a high-risk COVID-19 exposure can help prevent you from becoming sick. It is designed for people who currently have no symptoms but had a significant exposure to someone with confirmed COVID-19.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Have no COVID-19 symptoms when you start the study
- Have had a high-risk exposure without masks (like living in the same household as someone with confirmed COVID-19), and the start test is negative
- You must be able to swallow tablets
- Not use medicines that affect the immune system (like steroid pills) in the last 4 weeks
- Not be able to get other FDA-approved COVID-19 prevention treatment for your situation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called MDX2301 to see if it's safe in healthy adults and in adults who are at higher risk for severe COVID-19. Higher risk means you have conditions like asthma, diabetes, heart disease, or other listed health issues.
This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.
This trial tests whether an essential oil-based preparation is safe and effective for adults with mild to moderate COVID-19. It could be an option if you are not severely ill and are not taking other COVID treatments.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This trial tests whether an optimized antiviral treatment can help people with weakened immune systems who have COVID-19. It aims to find the best way to treat them to prevent severe illness.
This study looks at how long-term COVID affects your body and tests an exercise program to help with recovery. It compares people with long COVID to those who recovered fully.
Hear when a new SARS-CoV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.